NCT06286189View on ClinicalTrials.gov

Trazodone on OSA Endotypes

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

Placebo oral tablet

Placebo capsule taken 30 min before sleep

DRUG

Trazodone Hydrochloride

Trazodone 100 mg 30 min before sleep

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER